International Journal of Radiation Oncology * Biology * Physics
Volume 47, Issue 5 , Pages 1191-1200 , 15 July 2000

Locoregional irradiation for inflammatory breast cancer: effectiveness of dose escalation in decreasing recurrence

  • Zhongxing Liao, M.D.

      Affiliations

    • Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
    • ,
  • Eric A Strom, M.D.

      Affiliations

    • Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
    • ,
  • Aman U Buzdar, M.D.

      Affiliations

    • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
    • ,
  • S.Eva Singletary, M.D.

      Affiliations

    • Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
    • ,
  • Kelly Hunt, M.D.

      Affiliations

    • Department of Breast Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
    • ,
  • Pamela K Allen, MPH

      Affiliations

    • Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
    • ,
  • Marsha D McNeese, M.D.

      Affiliations

    • Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
    • Corresponding Author InformationReprint requests to: Dr. Marsha D. McNeese, The University of Texas, M. D. Anderson Cancer Center, Department of Radiation Oncology, 1515 Holcombe Blvd., P.O. Box 97, Houston, TX 77030

,Accepted 9 December 1999.

References 

  1. Taylor GW, Meltzer A. Inflammatory carcinoma of the breast. Am J Cancer. 1938;33:33–49
  2. Haagensen C. Disease of the breast. 2nd ed. Philadelphia, PA: W. B. Saunders; 1971. p. 576–584.
  3. Levine PH, Steinhorn SC, Ries LG, et al.  Inflammatory breast cancer (The experience of the surveillance, epidemiology, and end results (SEER) Program). J Natl Cancer Inst. 1985;74:291–297
  4. Barker JL, Nelson AJ, Montague ED. Inflammatory carcinoma of the breast. Radiology. 1976;121:173–176
  5. Buzdar AU, Singletary SE, Booser DJ, et al.  Combined modality treatment of stage III and inflammatory breast cancer. M. D. Anderson Cancer Center experience. Surg Oncol Clin North Am. 1995;4:715–734
  6. Zylberberg B, Salat-Baroux J, Ravina JH, et al.  Initial chemoimmunotherapy in inflammatory carcinoma of the breast. Cancer. 1982;49:1537–1543
  7. Rouesse J, Friedman S, Sarrazin D, et al.  Primary chemotherapy in the treatment of inflammatory breast carcinoma (A study of 230 cases from the Institut Gustave-Roussy). J Clin Oncol. 1986;4:1765–1771
  8. Chevallier B, Bastit P, Craic Y, et al.  The Centre H. Becquerel studies in inflammatory non metastatic breast cancer. Combined modality approach in 178 patients. Br J Cancer. 1993;67:594–601
  9. Maloisel F, Dufour P, Bergerat JP, et al.  Results of initial doxorubicin, 5-fluorouracil, and cyclophosphamide combination chemotherapy for inflammatory carcinoma of the breast. Cancer. 1990;65:851–855
  10. Perez CA, Fields JN, Fracasso PM, et al.  Management of locally advanced carcinoma of the breast. II. Inflammatory carcinoma. Cancer. 1994;74:466–476
  11. Israel L, Breau JL, Morere JF. Two years of high-dose cyclophosphamide and 5-fluorouracil followed by surgery after 3 months for acute inflammatory breast carcinomas. As phase II study of 25 cases with a median follow-up of 35 months. Cancer. 1986;57:24–28
  12. Elias EG, Vachon DA, Didolkar MS, et al.  Long-term results of a combined modality approach in treating inflammatory carcinoma of the breast. Am J Surg. 1991;162:231–235
  13. Barker JL, Montague ED, Peters LJ. Clinical experience with irradiation of inflammatory carcinoma of the breast with and without elective chemotherapy. Cancer. 1980;45:625–629
  14. Thoms WJ, McNeese MD, Fletcher GH, et al.  Multimodality treatment for inflammatory breast cancer [letter; comment]. Int J Radiat Oncol Biol Phys. 1990;19:1107
  15. Beahrs OH, Henson DE, Hutter RV; et al., editors. American Joint Committee on Cancer: Manual for staging of cancer. Philadelphia, J.B. Lippincott; 1988.
  16. Ueno NT, Buzdar AU, Singletary SE, et al.  Combined-modality treatment of inflammatory breast carcinoma (Twenty years of experience at M. D. Anderson Cancer Center). Cancer Chemother Pharmacol. 1997;40:321–329
  17. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Statst Assoc. 1958;53:457–481
  18. Overgaard M, Hansen PS, Overgaard J, et al.  Postoperative radiotherapy in high-risk premenopausal women with breast cancer who received adjuvant chemotherapy. Danish breast cancer cooperative group 82b trial. N Engl J Med. 1997;337:949–955
  19. Ragaz J, Jackson SM, Le N, et al.  Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med. 1997;337:956–962
  20. Thomas F, Arriagada R, Spielmann M, et al.  Pattern of failure in patients with inflammatory breast cancer treated by alternating radiotherapy and chemotherapy. Cancer. 1995;76:2286–2290
  21. Brun B, Otmezguine Y, Feuilhade F, et al.  Treatment of inflammatory breast cancer with combination chemotherapy and mastectomy versus breast conservation. Cancer. 1988;61:1096–1103
  22. Pisansky TM, Schaid DJ, Loprinzi CL, et al.  Inflammatory breast cancer (Integration of irradiation, surgery, and chemotherapy). Am J Clin Oncol. 1992;15:376–387

PII: S0360-3016(00)00561-7

doi: 10.1016/S0360-3016(00)00561-7

International Journal of Radiation Oncology * Biology * Physics
Volume 47, Issue 5 , Pages 1191-1200 , 15 July 2000

Article Tools

* Image Usage & Resolution